1. Home
  2. CLDX vs RBCAA Comparison

CLDX vs RBCAA Comparison

Compare CLDX & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • RBCAA
  • Stock Information
  • Founded
  • CLDX N/A
  • RBCAA 1974
  • Country
  • CLDX United States
  • RBCAA United States
  • Employees
  • CLDX N/A
  • RBCAA N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RBCAA Major Banks
  • Sector
  • CLDX Health Care
  • RBCAA Finance
  • Exchange
  • CLDX Nasdaq
  • RBCAA Nasdaq
  • Market Cap
  • CLDX 1.3B
  • RBCAA 1.3B
  • IPO Year
  • CLDX 2008
  • RBCAA 1998
  • Fundamental
  • Price
  • CLDX $20.66
  • RBCAA $68.57
  • Analyst Decision
  • CLDX Buy
  • RBCAA Hold
  • Analyst Count
  • CLDX 9
  • RBCAA 1
  • Target Price
  • CLDX $50.00
  • RBCAA N/A
  • AVG Volume (30 Days)
  • CLDX 843.8K
  • RBCAA 32.6K
  • Earning Date
  • CLDX 08-07-2025
  • RBCAA 07-18-2025
  • Dividend Yield
  • CLDX N/A
  • RBCAA 2.64%
  • EPS Growth
  • CLDX N/A
  • RBCAA 27.68
  • EPS
  • CLDX N/A
  • RBCAA 6.28
  • Revenue
  • CLDX $5,790,000.00
  • RBCAA $369,212,000.00
  • Revenue This Year
  • CLDX N/A
  • RBCAA $14.17
  • Revenue Next Year
  • CLDX N/A
  • RBCAA $10.87
  • P/E Ratio
  • CLDX N/A
  • RBCAA $10.89
  • Revenue Growth
  • CLDX N/A
  • RBCAA 16.32
  • 52 Week Low
  • CLDX $14.40
  • RBCAA $54.88
  • 52 Week High
  • CLDX $47.00
  • RBCAA $80.68
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 40.75
  • RBCAA 38.31
  • Support Level
  • CLDX $20.65
  • RBCAA $67.75
  • Resistance Level
  • CLDX $22.60
  • RBCAA $69.05
  • Average True Range (ATR)
  • CLDX 1.11
  • RBCAA 1.35
  • MACD
  • CLDX -0.28
  • RBCAA -0.52
  • Stochastic Oscillator
  • CLDX 10.64
  • RBCAA 19.98

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

Share on Social Networks: